RNA Interference Mediated Silencing of Tissue Factor in Human Umbilical Vein Endothelial Cells  

作　　者：Xiaojuan Yin Zhu Chen Weiqin Zhou Wen Tang Zhichun Feng 

机构地区：[1]Bayi Children’s Hospital Affiliated to Army General Hospital of People’s Liberation Army, Beijing, China

出　　处：《Open Journal of Obstetrics and Gynecology》2018年第5期477-484,共8页妇产科期刊（英文）

摘　　要：Objective: To construct to silence tissue factor (TF) expression in Human Umbilical Vein Endothelial Cells (HUVECs) for providing evidence of the gene therapy and prevention of coagulation dysfunction in placental abruption (PA) neonates. Methods: Cultured HUVECs in vitro were divided into control group and PA group, each including non-prevention, scramble siRNA and TF-siRNA subgroups. pENTRTM/U6-shRNA/TF vector expressing TF were constructed and transfected into HUVECs. The mRNA expression of TF was tested with RT-PCR, and TF protein expression was detected with immunofluorescence staining. Results: Monolayer HUVECs with short-rod and short spindle shaped were adherent to the bottom, forming paving stone arrangement. The TF mRNA expression was significantly different between control group and PA group (P 0.01) and among different subgroups (P 0.01). In non-prevention subgroups, significant difference was observed in TF mRNA expression between control group and PA group (P 0.05). Significant difference in TF mRNA expression was found in false-prevention subgroups (P 0.05). The TF mRNA expression was markedly different among different subgroups in control (P 0.01), and the similar result among different PA subgroups (P 0.01). In both control and PA groups, the TF mRNA expression was the lowest after TF silencing. Immunofluorescence staining showed high TF expression in HUVECs in false-prevention subgroups. In scramble siRNA group, the TF protein expression reduced as compared to non-prevention group and reduced dramatically after TF silencing as compared to control. Conclusion: pENTRTM/U6-TF-shRNA is able to significantly inhibit the TF mRNA and protein expression in HUVECs from healthy neonates and PA neonates.Objective: To construct to silence tissue factor (TF) expression in Human Umbilical Vein Endothelial Cells (HUVECs) for providing evidence of the gene therapy and prevention of coagulation dysfunction in placental abruption (PA) neonates. Methods: Cultured HUVECs in vitro were divided into control group and PA group, each including non-prevention, scramble siRNA and TF-siRNA subgroups. pENTRTM/U6-shRNA/TF vector expressing TF were constructed and transfected into HUVECs. The mRNA expression of TF was tested with RT-PCR, and TF protein expression was detected with immunofluorescence staining. Results: Monolayer HUVECs with short-rod and short spindle shaped were adherent to the bottom, forming paving stone arrangement. The TF mRNA expression was significantly different between control group and PA group (P 0.01) and among different subgroups (P 0.01). In non-prevention subgroups, significant difference was observed in TF mRNA expression between control group and PA group (P 0.05). Significant difference in TF mRNA expression was found in false-prevention subgroups (P 0.05). The TF mRNA expression was markedly different among different subgroups in control (P 0.01), and the similar result among different PA subgroups (P 0.01). In both control and PA groups, the TF mRNA expression was the lowest after TF silencing. Immunofluorescence staining showed high TF expression in HUVECs in false-prevention subgroups. In scramble siRNA group, the TF protein expression reduced as compared to non-prevention group and reduced dramatically after TF silencing as compared to control. Conclusion: pENTRTM/U6-TF-shRNA is able to significantly inhibit the TF mRNA and protein expression in HUVECs from healthy neonates and PA neonates.

关 键 词：NEONATE TISSUE Factor PLACENTAL ABRUPTION 

分 类 号：R73[医药卫生—肿瘤]